rabeprazole has been researched along with terbinafine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Berger, C; Fleckman, P; Johnstone, D | 1 |
| Andrade, RJ; Lucena, MI | 1 |
1 review(s) available for rabeprazole and terbinafine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for rabeprazole and terbinafine
| Article | Year |
|---|---|
Acute fulminant hepatitis after treatment with rabeprazole and terbinafine.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Antifungal Agents; Benzimidazoles; Chemical and Drug Induced Liver Injury, Chronic; Humans; Male; Middle Aged; Naphthalenes; Omeprazole; Rabeprazole; Terbinafine | 2001 |
Acute fulminant hepatitis after treatment with rabeprazole and terbinafine: is rabeprazole the culprit?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Benzimidazoles; Biopsy, Needle; Chemical and Drug Induced Liver Injury; Drug Interactions; Follow-Up Studies; Humans; Naphthalenes; Omeprazole; Rabeprazole; Risk Assessment; Severity of Illness Index; Terbinafine | 2002 |